Real-World study eyes melflufen for Late-Stage myeloma patients
Disease control
Not yet recruiting
This study watches how well the drug melflufen (Pepaxti®) combined with dexamethasone works in everyday medical practice for people with relapsed or refractory multiple myeloma. It includes 50 patients who have already tried at least three other treatments. The goal is to see how…
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated May 01, 2026 15:57 UTC